Note 14 - Business Segments

3 Months Ended

Sep. 30, 2023

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14.   BUSINESS SEGMENTS

The Company operated in four segments; the testing service industry (which performs structural and electronic tests of semiconductor devices), the designing and manufacturing of equipment (assembly of equipment that tests the structural integrity of integrated circuits and other products), distribution of various products from other manufacturers in Singapore and Asia and the real estate segment in China.

The cost of equipment, current year investment in new equipment and depreciation expense are allocated into respective segments based on the primary purpose for which the equipment was acquired.

Corporate expenses are allocated to the four segments on a combination of factors involving revenue, manpower costs and fixed assets investments, except the Malaysia and China operations, which is calculated based on actual sales. The following segment information table includes segment operating income or loss after including corporate expenses allocated to the segments, which gets eliminated in the consolidation.

The following segment Information is unaudited for the three months ended September 30, 2023, and September 30, 2022:

Business Segment Information:

	Three Months			Operating
	Ended	Net		Income /			Total		Depr. And		Capital
	Sept. 30,	Revenue		(Loss)			Assets		Amort.		Expenditures
Manufacturing	2023	$	2,885	$	(42	)	$	18,996	$	114	$	19
	2022	$	3,585	$	176		$	12,791	$	97	$	-
Testing Services	2023		5,164		(128	)		21,312		1,326		58
	2022		6,364		861			27,770		767		1,156
Distribution	2023		1,910		245			1,958		-		-
	2022		1,982		265			1,603		-		-
Real Estate	2023		7		(26	)		2,059		19		-
	2022		8		(14	)		1,490		18		-
Corporate & Unallocated	2023		-		(50	)		374		12		-
	2022		-		(221	)		151		-		-
Total Company	2023	$	9,966	$	(1	)	$	44,699	$	1,471	$	77
	2022	$	11,939	$	1,067		$	43,805	$	882	$	1,156

Management is currently evaluating the ongoing contributions of each of its business segments to its current and future revenue and prospects, including its testing segment. As a result, we may divest one or more business segments in the future, including its testing segment, to enable management to concentrate on segments where it anticipates opportunities for future revenue growth, thereby maximizing shareholder value.